Logo
C

Cytovance Biologics

198 employees

Welcome to Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for clinical and commercial production, our team is your team. Together, we will guide your asset through the complexities of manufacturing and deliver it to its next milestone. With a 95% scale-up success rate and quality, scalability, and reproducibility top of mind, we bring a range of therapeutic proteins and antibodies to the clinic, including: ● Biosimilars ● Cytokines ● Enzymes/Hormones ● Fusion Proteins ● Bispecific, Fragment, and Monoclonal Antibodies ● Recombinant Protein ● Vaccines ● And More We are the Responsible, Reliable, and Resourceful partner you and your product deserve.

Investor insights

Funding rounds participated in

$20M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2003

Funding rounds raised

Total raised

$20M

from investors over 1 rounds

C

Cytovance Biologics raised $20M on November 28, 2014

FAQ